Azin Vakilpour
@azinvkp
MD | Postdoctoral Research Fellow @Penncardiology @Pennmedicine🫀| Former Professional Chess Player♟️
Our new study is out in @AmericanHeartJ 🫀 In this multi-center study of 4,249 pts w/ severe AS: 📌42%, incl. 32% symptomatic AS, didn’t undergo AVR; rates impacted by provider specialty at diagnosis 📌 Gaps more pronounced in LF-LG AS 📌 Black pts less likely to receive AVR…

This AI screening model used only an apical 4ch echo videoclip & effectively differentiated cardiac amyloidosis from other causes of ⬆️ wall thickness
📢 New #EHJ study! Our AI screening tool for echo — EchoGo® Amyloidosis — detects cardiac amyloidosis, a life-threatening condition, with high accuracy. Developed with @MayoClinic @UChicago, tested with 18 global sites. See paper & release: ultromics.com/press-releases… #CardioTwitter
Pleased to be selected as a Top Investigator for the #ASE 36th Annual Scientific Sessions! Grateful to the ASE Foundation for this recognition and travel grant supporting my presentation! @ASE360 Looking forward to attending this September in Nashville! #ASE2025 @PennCardiology


Cancer therapies can carry CV risks, but current safety tools fall short. The Cardiac Safety Research Consortium led a multi-stakeholder think tank to improve CV safety reporting in oncology trials. Read the findings + next steps in #JACCCardioOnc: jacc.org/doi/10.1016/j.…
A recent study by @Dr_Mike_Fradley 🩺 et al. supports the use of SGLT2 inhibitors 💉 in transthyretin amyloid #cardiomyopathy, showing reduced HF exacerbations. Learn more 👉 spr.ly/6011Nx3ol #heartfailure
From 2016-2019, #SAVR remained financially stable while #TAVR saw declining margins, and hospitals w/ positive TAVR margins showed increased TAVR use vs SAVR. Read the full analysis 👉 spr.ly/6016Nx3OE @jaygirimd @wilson_szeto @NimeshDesaiMD @SameedKhatana @eberly_lauren
Valuable session today at @penncardiology grand rounds with Dr. @Ron_Witteles, discussing diagnostic challenges and therapeutic advances in cardiac amyloidosis

🚀Our latest paper is now published in the Journal of the American Medical Informatics Association (#JAMIA)! 🧠We shared complete prompts and detailed optimization samples! 🔍 Don't miss the supplementary materials for this! academic.oup.com/jamia/article-…
🚨 Join me and @EJPCEiC, Prof. @AboyansV, in our editorial discussing the science featured in the latest issue of #EJPC on the 🧠↔️🫀! 🔗tinyurl.com/EJPC-32-6-April @escardio @ESC_Journals @cards_lab @YaleCardiology @YaleIMed
The @PennMedicine #HFpEF Symposium is in ONE MONTH! Save your spot ➡️ spr.ly/6019FHujP #CME #HeartFailure #HeartFailureCME #Cardiology #PaymanZamaniMD
@MKIttlesonMD we are all so fortunate to learn from you. Congratulations on receiving the 2025 @ACCinTouch Distinguished Teacher Award! #kittlesonrules @CaliforniaACC @SmidtHeart @CedarsCards
And #ACC25 concludes but the journey continues! @ACCinTouch @ACCMaryland @Drroxmehran @CathieBiga @ditchhaporia @ChrisKramerMD @Pooh_Velagapudi @SarasVallabhMD @Mod_Pharmacist @KimMed_ @RThachilMD @PA_Kotta @ujebubechukwu @Ibrahim_Kamel9 @DrHaloot @EspicheCarlos @drapura1…
Wrapped up another ACC✅ Feeling so grateful to know these amazing pals and inspiring mentors. Couldn’t ask for a better experience in Chicago!☺️
Check out @EliMahMD ‘s #ACC25 presentation, “Prompt Optimization and Chain of Thought Reasoning for Automated Classification of Echo Reports Using Privacy-Preserving Open-Source Language Models” TODAY!
Loved being at ACC25 — presented my posters, reconnected with friends, and learned so much from inspiring experts and role models! Already excited for future meetings! @ACCinTouch @PennCardiology




📰 Checkout our latest publication in JACC: Advances! We evaluated antithrombotic strategies post-TAVR in patients w/out indication for anticoagulation. SAPT emerges as the safest option—lower bleeding risk without ↑ mortality, MI, or stroke.🫀#CardioTwitter #TAVR @JACCJournals
A #JACCAdvances updated network meta-analysis confirms that SAPT remains the safest choice for pts w/out indication for anticoagulation, significantly reducing 🩸 risk w/out 📈 mortality, #cvMI, or stroke risks. Personalized care remains essential. jacc.org/doi/10.1016/j.… #ACC25
Amazing presentation by @AryaAminorroaya @cards_lab at @ACCinTouch #ACC25 YIA for Clinical Investigations An individual participant analysis of SURPASS trials evaluating the cardiometabolic effects of tirzepatide Simultaneously published in @JACCJournals #JACC (link below)
ACC25: PKP2 haploinsufficiency can cause ventricular arrhythmia years before structural changes emerge. Grateful for Dr. Giudicessi’s mentorship. @ACCinTouch @JohnGiudicessi @MayoCVFellows @MayoClinicCV
Great insights from Dr. @SammyElmariahMD at #ACC25 on the impact of electronic provider notifications in increasing AVR rates for severe AS.

🌟I’ll be presenting 3 of our works @MayoAILab at #ACC25 over the next two days! LLMs, segmentation and ML CVD risk prediction! Excited to share our work and connect with fellow researchers + clinicians passionate about AI🤖and cardiology❤️. Come say hi!👋 @ACCinTouch @Slowvak